Biotage AB (publ)
BITGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13,129,382 | $8,924,869 | $11,673,222 | $17,384,135 |
| - Cash | $434,000 | $594,000 | $441,000 | $311,000 |
| + Debt | $250,000 | $259,000 | $217,000 | $203,000 |
| Enterprise Value | $12,945,382 | $8,589,869 | $11,449,222 | $17,276,135 |
| Revenue | $2,056,000 | $1,862,000 | $1,566,000 | $1,232,000 |
| % Growth | 10.4% | 18.9% | 27.1% | – |
| Gross Profit | $1,289,000 | $1,149,000 | $948,000 | $755,000 |
| % Margin | 62.7% | 61.7% | 60.5% | 61.3% |
| EBITDA | $530,000 | $465,000 | $454,000 | $347,000 |
| % Margin | 25.8% | 25% | 29% | 28.2% |
| Net Income | $284,000 | $246,000 | $268,000 | $205,000 |
| % Margin | 13.8% | 13.2% | 17.1% | 16.6% |
| EPS Diluted | 3.55 | 0.33 | 0.39 | 0.34 |
| % Growth | 975.8% | -15.4% | 14.7% | – |
| Operating Cash Flow | $413,000 | $284,000 | $341,000 | $353,000 |
| Capital Expenditures | -$169,000 | -$91,000 | -$70,000 | -$56,000 |
| Free Cash Flow | $244,000 | $193,000 | $271,000 | $297,000 |